Fundraising FoxAyalapharma
2 known investors
Find your way into Ayalapharma
Sign up to see every warm intro you have to Ayalapharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ayalapharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ayala Pharma is associated with pharmaceutical drug candidates including AL102, AL101, and BST-236; the page states that AL102 and AL101 were acquired by Immunome, Inc. in Q1 2024.
Investors · 2
Frequently asked questions
- What does Ayalapharma do?
- Ayala Pharma is associated with pharmaceutical drug candidates including AL102, AL101, and BST-236; the page states that AL102 and AL101 were acquired by Immunome, Inc. in Q1 2024.
- Who are Ayalapharma's investors?
- Ayalapharma's investors include aMoon, Israel Biotech Fund.